Wall Street Journal Recognizes Vidacare Corporation for Second Time: OnControl Bone Marrow System Receives 2012 Overall Bronze Technology Innovation Award and Top Award in the Medical Devices Category

SAN ANTONIO--(BUSINESS WIRE)--The Wall Street Journal announced the winners of its 2012 Technology Innovation Awards today, and for the second time, Vidacare Corporation has been recognized for its ground-breaking technology. Vidacare’s OnControl^® Bone Marrow System is the overall Bronze winner in this year’s Technology Innovation Awards and the winner of the Medical Devices category. Vidacare’s EZ-IO^® Intraosseous Infusion System won the overall Gold Technology Innovation of the Year award from the same program in 2008.

“The entire team at Vidacare is thrilled to be recognized for a second time by the Wall Street Journal”

In its twelfth annual competition, the Wall Street Journal received over 500 nominations from around the world, with only seven percent receiving recognition from the program. Complete coverage of the 2012 awards can be found in The Wall Street Journal’s three global editions today, as well as online at: www.WSJ.com/Reports.

The OnControl^® Bone Marrow System combines a specially-designed needle and powered driver to provide the first significant advance in bone marrow biopsy technology in over 40 years. OnControl is proven to offer high quality, safe, reliable and less painful bone marrow procedures, with consistently better samples, benefitting both patients and clinicians.

“The entire team at Vidacare is thrilled to be recognized for a second time by the Wall Street Journal,” said Mark Mellin, President and Chief Executive Officer of Vidacare Corporation. “Our passion is to help patients in need, and this honor is further acknowledgement that we are succeeding in that endeavor.”

Established in 2001, Vidacare Corporation is the pioneer of a broad technology platform for accessing the intraosseous (inside the bone) space. Current products include the EZ-IO^® Intraosseous Infusion System, the OnControl^® Bone Marrow System and the OnControl^® Bone Access System. Applications include vascular access, emergency and disaster medicine, oncology and spinal surgery. Vidacare’s focus on enhancing clinical efficacy, patient safety and comfort, and reducing complications and their associated costs, has resulted in its devices becoming the recognized technology standard. Privately held, the company is based in San Antonio, Texas, and its products are marketed in over 50 countries worldwide. www.vidacare.com